文献速递肾小球疾病

肾脏活检转录组学:肾脏病精准治疗中尚未开发的资源——系统综述

Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该综述系统检索数据库共获得716篇文章,最终纳入19篇相关文献,总结了转录组学在微小病变、局灶节段性肾小球硬化、IgA肾病、狼疮性肾炎和糖尿病肾病等肾小球疾病活检组织分子分析中的应用。转录组学为肾小球疾病提供了有前景的新基因靶点见解,并可能通过整合系统药理学预测逆转病理状态的最佳药物组合。

要点

  • 转录组学可分析肾脏活检全基因表达谱,补充肾小球疾病发病机制认识。
  • 综述纳入19篇文献,涉及微小病变、FSGS、IgA肾病、狼疮性肾炎和糖尿病肾病。
  • 转录组学与系统药理学整合有望预测靶向疾病分子网络的最佳药物组合。

核心结论

  • 转录组学是精准肾脏病学尚未开发的资源。
  • 转录组学与系统药理学整合可靶向疾病特异性分子网络,预测逆转病理状态的最佳药物组合。

研究设计与样本

  • 系统综述,通过数据库检索获得716篇文章,最终纳入19篇相关文献。
  • 综述聚焦肾小球疾病活检组织转录组学分子分析,疾病包括微小病变、局灶节段性肾小球硬化、IgA肾病、狼疮性肾炎和糖尿病肾病。

主要发现

  • 肾脏活检转录组学在多种肾小球疾病中产生了关于若干有前景基因的新见解,各疾病章节均有阐述。
  • 这些基因可能被视为上述疾病治疗的重要靶点。

临床怎么用

  • 转录组学可基于冷冻或福尔马林固定石蜡包埋肾脏活检组织开展高通量基因表达分析。
  • 转录组学结果可单独或与其他组学数据整合,用于改善对肾小球病发病机制的认识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The diagnosis of glomerular diseases is based on the evaluation of histological lesions in renal tissue by means of light and electronic microscopy, and immunofluorescence technique. Frozen and archival formalin-fixed paraffin-embedded kidney biopsies represent a stored resource for high-throughput technologies. Transcriptomics makes it possible to study the whole gene-expression profile of cells and tissues in a specific period and/or condition. The results, whether considered alone or integrated with other omics data, could help to improve existing knowledge about the pathogenetic mechanisms of glomerulopathies. METHODS: This review describes the molecular analysis of histological lesions obtained by transcriptomics in glomerular diseases, such as minimal change disease, focal and segmental glomerular sclerosis, IgA nephropathy, lupus nephritis and diabetic nephropathy. RESULTS: Of 716 articles obtained through database searches, 19 relevant articles were considered for the systematic review. Transcriptomics in kidney biopsy from patients with glomerular diseases have generated new insights on a few promising genes, illustrated in each disease section, which may be considered important targets for the care of these diseases. CONCLUSIONS: Transcriptomics is an untapped resource for precision nephrology. Moreover, the integration of transcriptomics and systems pharmacology could predict the best drug combination to revert a pathological condition by targeting disease-specific molecular networks.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Schena FP, Nistor I, Curci C, et al. Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review. Nephrol Dial Transplant. 2018. PMID: 28992289. doi:10.1093/ndt/gfx211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。